SEC Form D · filed January 4, 2021
EYEGATE PHARMACEUTICALS INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Keith Maher · Waltham, MADirectorStephen From · Waltham, MAExec · DirectorSteven Boyd · Waltham, MADirectorPraveen Tyle · Waltham, MADirectorBernard Malfroy-Camine · Waltham, MADirectorThomas Hancock · Waltham, MADirectorSarah Romano · Waltham, MAExecMorton Goldberg · Waltham, MADirectorPaul Chaney · Waltham, MADirectorRodney D. Brown · LEESBURG, VAExec · DirectorJay Lee · Redmond, WADirectorTom Bruderman · Redmond, WADirectorTony Wood · Vancouver, British Columbia, CanadaDirectorScott Fletcher · Ross, CADirectorDaniel Wachtler · Redmond, WADirectorRandy H. Hopkins · Meridian, IDDirectorJustin Jory · Woodbridge, VADirectorDavid Wurtzbacher · Woodbridge, VAExecBrian Mcveigh · Hatfield, PADirectorJohn Iadeluca · New York, NYDirectorAccumulus Capital Partners, LLC · New York, NYDirectorSoutheast Asset Advisors, LLC · Thomasville, GADirectorAmir Nashat · CAMBRIDGE, MADirectorPaula Ragan · CAMBRIDGE, MADirectorRichard Young · CAMBRIDGE, MAExecJosh Mandel-Brehm · CAMBRIDGE, MAExec · DirectorJoshua G. Kazam · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗